RecruitingNot ApplicableNCT05056844

Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple Discharge

Contrast Enhanced Spectral Mammography (CESM) for the Evaluation of Pathologic Nipple Discharge: A Pilot Study


Sponsor

M.D. Anderson Cancer Center

Enrollment

66 participants

Start Date

Apr 15, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

This clinical trial studies contrast enhanced spectral mammography (CESM) for the evaluation of pathologic nipple discharge. CESM is similar to standard mammography, but it includes an intravenous (by vein) injection of an iodine-based contrast, which makes tissue and blood vessels more visible in scans. The goal of this trial is to learn if CESM, is better than standard mammography in quickly and efficiently determining the cause of nipple discharge and detecting breast cancer, if present. CESM may increase the chance of finding breast cancers and lower the risk of having unnecessary biopsies.


Eligibility

Sex: FEMALEMin Age: 25 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This study tests a special type of mammogram — called contrast-enhanced spectral mammography (CESM) — to see how well it finds the cause of nipple discharge (fluid leaking from the nipple). Doctors inject a small amount of contrast dye through an IV to help highlight abnormal areas in the breast. **You may be eligible if...** - You are a woman aged 25–85 - You are being evaluated for nipple discharge as a main or accompanying symptom - You are willing to have an IV placed and receive contrast dye **You may NOT be eligible if...** - You have had an allergic reaction to contrast dye (iodine-based) - You have kidney problems - You are pregnant or breastfeeding, or were within the last 6 months - You had breast surgery or a breast biopsy near the nipple within the last 2–6 months - You had a breast MRI within the last 2 years - You have known breast cancer or an active infection in the breast Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREContrast Enhanced Digital Mammography

Undergo CESM

PROCEDUREDigital Tomosynthesis Mammography

Undergo DBT

DRUGIodinated Contrast Agent

Given iodine-based contrast agent IV

OTHERQuestionnaire Administration

Ancillary studies


Locations(1)

M D Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05056844


Related Trials